申请人:Shionogi & Co., Ltd.
公开号:US04041026A1
公开(公告)日:1977-08-09
1,5-Dihydro-2H-1,4-benzodiazepin-2-one derivatives of the formula: ##STR1## (wherein Ar represents pyridyl, phenyl, or halogenophenyl; R represents C.sub.1 -C.sub.6 alkyl or C.sub.1 -C.sub.6 alkyl substituted by a member selected from the group consisting of trifluoromethyl, cyano, carbamoyl, C.sub.2 -C.sub.10 dialkylamino, and hydroxy; R.sup.1 represents halogen, nitro, trifluoromethyl, or cyano; and R.sup.2 represents C.sub.1 -C.sub.6 alkyl or C.sub.1 -C.sub.6 alkyl substituted by a member selected from the group consisting of halogen, hydroxy, and C.sub.1 -C.sub.6 alkoxy), being useful as anxiolytics, sedatives, anticonvulsants, hypnotics, or their synthetic intermediates, are prepared.
公式为:##STR1## 的1,5-二氢-2H-1,4-苯并二氮平-2-酮衍生物(其中Ar代表吡啶基,苯基或卤代苯基;R代表C.sub.1-C.sub.6烷基或C.sub.1-C.sub.6烷基被三氟甲基,氰基,氨基甲酰,C.sub.2-C.sub.10二烷基胺和羟基中的一种取代;R.sup.1代表卤素,硝基,三氟甲基或氰基;R.sup.2代表C.sub.1-C.sub.6烷基或C.sub.1-C.sub.6烷基被卤素,羟基和C.sub.1-C.sub.6烷氧基中的一种取代),可用作抗焦虑药,镇静剂,抗惊厥药,催眠药或其合成中间体。